Moderna Publishes Positive Phase 3 Clinical Data for mRNA-1010 Seasonal Influenza Vaccine in New England Journal of Medicine
CAMBRIDGE, Mass., May 6, 2026 Moderna announced the publication of pivotal Phase 3 clinical safety and efficacy data for...
Phase 3 trial
Advertisement
Aurion Biotech Highlights AURN001 Cell Therapy at ASGCT 2026
Seattle, WA; Cambridge, MA; Tokyo, Japan – May 6, 2026 Aurion Biotech, Inc. announced that it will deliver an...
Oculis Holding AG Secures FDA SPA for Privosegtor Optic Neuritis Phase 3 Trial
ZUG, Switzerland – May 7, 2026 Oculis Holding AG announced that the U.S. Food and Drug Administration (FDA) has...
Alebund Pharma Completes Phase 3 AP301 Enrollment
SHANGHAI, China – May 6, 2026 Alebund Pharmaceuticals (Jiangsu) Limited has announced the completion of patient enrollment in its...
Viridian Therapeutics Reports Positive REVEAL-2 Results
WALTHAM, Mass., United States – May 5, 2026 Viridian Therapeutics Inc. has announced positive topline results from its Phase...
Advertisements
Nanobiotix Updates Phase 3 NANORAY-312 Protocol
PARIS, France and CAMBRIDGE, Mass., United States – May 4, 2026 Nanobiotix has announced FDA acceptance of a protocol...
GRIN Therapeutics Initiates Phase 3 Beeline Study
NEW YORK, NY, May 4, 2026 GRIN Therapeutics, Inc. has announced the initiation of its pivotal Phase 3 Beeline...
Celcuity Reports Phase 3 Success for Gedatolisib in Breast Cancer
MINNEAPOLIS, MINNESOTA, May 01, 2026 Celcuity has announced positive topline results from its Phase 3 VIKTORIA-1 trial, demonstrating a...
Merck Enpatoran Enters Phase 3 Trial for Lupus Treatment
Darmstadt, Germany | April 30, 2026 Merck has announced the first patient dosing in its global Phase 3 ELOWEN...
Rezolute, Inc. Reports Phase 3 sunRIZE Data in HI
REDWOOD CITY, Calif., May 01, 2026 Rezolute, Inc. has announced detailed results from its Phase 3 sunRIZE study evaluating...
Advertisement
